Central Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Sell |
2,068
-64
| -3% | -$33.6K | 0.18% | 101 |
|
|
2025
Q1 | $1.35M | Buy |
2,132
+443
| +26% | +$281K | 0.23% | 90 |
|
|
2024
Q4 | $1.2M | Sell |
1,689
-259
| -13% | -$184K | 0.18% | 88 |
|
|
2024
Q3 | $2.05M | Buy |
1,948
+650
| +50% | +$683K | 0.28% | 71 |
|
|
2024
Q2 | $1.36M | Sell |
1,298
-78
| -6% | -$82K | 0.19% | 85 |
|
|
2024
Q1 | $1.32M | Sell |
1,376
-111
| -7% | -$107K | 0.19% | 85 |
|
|
2023
Q4 | $1.31M | Sell |
1,487
-95
| -6% | -$83.4K | 0.2% | 88 |
|
|
2023
Q3 | $1.3M | Buy |
1,582
+8
| +0.5% | +$6.58K | 0.23% | 83 |
|
|
2023
Q2 | $1.13M | Sell |
1,574
-33
| -2% | -$23.7K | 0.19% | 95 |
|
|
2023
Q1 | $1.32M | Buy |
1,607
+120
| +8% | +$98.6K | 0.24% | 82 |
|
|
2022
Q4 | $1.07M | Sell |
1,487
-34
| -2% | -$24.5K | 0.2% | 92 |
|
|
2022
Q3 | $1.05M | Sell |
1,521
-425
| -22% | -$293K | 0.23% | 87 |
|
|
2022
Q2 | $1.15M | Sell |
1,946
-558
| -22% | -$330K | 0.23% | 82 |
|
|
2022
Q1 | $1.75M | Buy |
2,504
+113
| +5% | +$78.9K | 0.28% | 73 |
|
|
2021
Q4 | $1.51M | Buy |
2,391
+120
| +5% | +$75.8K | 0.23% | 81 |
|
|
2021
Q3 | $1.37M | Sell |
2,271
-86
| -4% | -$52K | 0.23% | 85 |
|
|
2021
Q2 | $1.32M | Sell |
2,357
-1,086
| -32% | -$606K | 0.21% | 81 |
|
|
2021
Q1 | $1.63M | Sell |
3,443
-994
| -22% | -$470K | 0.28% | 75 |
|
|
2020
Q4 | $2.14M | Sell |
4,437
-3,437
| -44% | -$1.66M | 0.37% | 70 |
|
|
2020
Q3 | $4.41M | Buy |
7,874
+316
| +4% | +$177K | 0.83% | 41 |
|
|
2020
Q2 | $4.71M | Buy |
+7,558
| New | +$4.71M | 0.93% | 34 |
|
|
2019
Q3 | – | Sell |
-9
| Closed | -$3K | – | 299 |
|
|
2019
Q2 | $3K | Sell |
9
-11,082
| -100% | -$3.69M | ﹤0.01% | 255 |
|
|
2019
Q1 | $4.55M | Buy |
11,091
+721
| +7% | +$296K | 1.02% | 36 |
|
|
2018
Q4 | $3.87M | Buy |
+10,370
| New | +$3.87M | 0.98% | 32 |
|